In the context of significant strides in infectious disease control, recent outbreaks, including SARS, H1N1 influenza, Ebola, resurgent measles, and the novel Coronavirus, remain substantial threats to global health. Despite the proven efficacy and safety of vaccines, a troubling surge in vaccine hesitancy, notably pronounced in Europe, has resulted in increased vaccine refusal and a decline in routine immunization coverage. Widespread misconceptions, such as the belief in low disease prevalence post-immunization success, contribute to a reduced sense of urgency for vaccination. Mathematical modeling and computer simulations have emerged as indispensable tools for probing infectious disease dynamics and assessing the impact of vaccination strategies. Recent modeling endeavors transcend traditional assumptions, incorporating realistic demographic patterns and social interactions. However, the understanding of mechanisms steering behavioral responses to risk perception remains in its early stages, emphasizing the need for further research to inform policy decisions. The overarching goal of the IMMUNE project is to advance the epidemiological modeling framework by integrating human behaviors and their interconnections with underlying epidemiological processes. To achieve this, the IMMUNE project will: i) gather nationally representative data from selected EU countries on human perceptions and behaviors regarding infectious diseases, vaccine risks, and vaccination programs, analyze their spatial distribution within and between countries and their temporal dynamics; ii) explore the importance of peers' influence and network effects on individual's intentions regarding vaccination and other preventive behaviors; iii) develop infection-specific population and agent-based epidemiological models informed with the gathered country-specific behavioral data and assess the bidirectional effects and the interdependencies between the epidemiological process and the behavioral components. This comprehensive approach aims to enhance our understanding of the intricate interplay between human behaviors, vaccine acceptance, and infectious disease dynamics, ultimately contributing to informed and effective public health policies.